Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.240
+0.080 (1.92%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $8.52 million as of July 20, 2026. Its market cap has increased by 68.35% in one year.
Market Cap
8.52M
Enterprise Value
-3.35M
1-Year Change
68.35%
Ranking
Category
Stock Price
$4.24
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $8.52M, a decrease of -91.24%. That is a compound annual growth rate of -40.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 8.52M | -29.66% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 9.45M |
| Curis | 9.30M |
| BioRestorative Therapies | 9.15M |
| MetaVia | 8.73M |
| Aprea Therapeutics | 8.45M |
| Bolt Biotherapeutics | 8.19M |
| Ernexa Therapeutics | 8.11M |
| Aspire Biopharma Holdings | 7.97M |